Raymond Anderson - Net Worth and Insider Trading

Raymond Anderson Net Worth

The estimated net worth of Raymond Anderson is at least $60,255 dollars as of 2024-04-18. Raymond Anderson is the Director of Raptor Pharmaceutical Corp and owns about 6,695 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $60,255. Details can be seen in Raymond Anderson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Raymond Anderson has not made any transactions after 2015-09-02 and currently still holds the listed stock(s).

Transaction Summary of Raymond Anderson

To

Raymond Anderson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raymond Anderson owns 2 companies in total, including Monopar Therapeutics Inc (MNPR) , and Raptor Pharmaceutical Corp (RPTP) .

Click here to see the complete history of Raymond Anderson’s form 4 insider trades.

Insider Ownership Summary of Raymond Anderson

Ticker Comapny Transaction Date Type of Owner
MNPR Monopar Therapeutics Inc 2022-12-31 director
RPTP Raptor Pharmaceutical Corp 2016-10-24 director

Raymond Anderson Latest Holdings Summary

Raymond Anderson currently owns a total of 1 stock. Raymond Anderson owns 6,695 shares of Raptor Pharmaceutical Corp (RPTP) as of September 2, 2015, with a value of $60,255.

Latest Holdings of Raymond Anderson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RPTP Raptor Pharmaceutical Corp 2015-09-02 6,695 9.00 60,255

Holding Weightings of Raymond Anderson


Raymond Anderson Form 4 Trading Tracker

According to the SEC Form 4 filings, Raymond Anderson has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 4,916 shares on September 2, 2015, which brought Raymond Anderson around $61,499.

Insider Trading History of Raymond Anderson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Raymond Anderson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Raymond Anderson Ownership Network

Ownership Network List of Raymond Anderson

No Data

Ownership Network Relation of Raymond Anderson


Raymond Anderson Owned Company Details

What does Monopar Therapeutics Inc do?

Who are the key executives at Monopar Therapeutics Inc?

Raymond Anderson is the director of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Financial Officer Kim R Tsuchimoto , director & Chief Executive Officer Chandler Robinson , and other: Acting Chief Medical Officer Patrice Rioux .

Monopar Therapeutics Inc (MNPR) Insider Trades Summary

Over the past 18 months, Raymond Anderson made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 16,053 shares made by Andrew Cittadine ,

In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 16,053 shares were bought by its insiders, resulting in a net purchase of 16,053 shares.

Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Monopar Therapeutics Inc Insider Transactions

No Available Data

Raymond Anderson Mailing Address

Above is the net worth, insider trading, and ownership report for Raymond Anderson. You might contact Raymond Anderson via mailing address: C/o Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350, Wilmette Il 60091.

Discussions on Raymond Anderson

No discussions yet.